Literature DB >> 32880609

Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases.

Philippe Burlina1,2,3, William Paul1, Philip Mathew1, Neil Joshi1, Katia D Pacheco4, Neil M Bressler2,5.   

Abstract

Importance: Recent studies have demonstrated the successful application of artificial intelligence (AI) for automated retinal disease diagnostics but have not addressed a fundamental challenge for deep learning systems: the current need for large, criterion standard-annotated retinal data sets for training. Low-shot learning algorithms, aiming to learn from a relatively low number of training data, may be beneficial for clinical situations involving rare retinal diseases or when addressing potential bias resulting from data that may not adequately represent certain groups for training, such as individuals older than 85 years. Objective: To evaluate whether low-shot deep learning methods are beneficial when using small training data sets for automated retinal diagnostics. Design, Setting, and Participants: This cross-sectional study, conducted from July 1, 2019, to June 21, 2020, compared different diabetic retinopathy classification algorithms, traditional and low-shot, for 2-class designations (diabetic retinopathy warranting referral vs not warranting referral). The public domain EyePACS data set was used, which originally included 88 692 fundi from 44 346 individuals. Statistical analysis was performed from February 1 to June 21, 2020. Main Outcomes and Measures: The performance (95% CIs) of the various AI algorithms was measured via receiver operating curves and their area under the curve (AUC), precision recall curves, accuracy, and F1 score, evaluated for different training data sizes, ranging from 5120 to 10 samples per class.
Results: Deep learning algorithms, when trained with sufficiently large data sets (5120 samples per class), yielded comparable performance, with an AUC of 0.8330 (95% CI, 0.8140-0.8520) for a traditional approach (eg, fined-tuned ResNet), compared with low-shot methods (AUC, 0.8348 [95% CI, 0.8159-0.8537]) (using self-supervised Deep InfoMax [our method denoted as DIM]). However, when far fewer training images were available (n = 160), the traditional deep learning approach had an AUC decreasing to 0.6585 (95% CI, 0.6332-0.6838) and was outperformed by a low-shot method using self-supervision with an AUC of 0.7467 (95% CI, 0.7239-0.7695). At very low shots (n = 10), the traditional approach had performance close to chance, with an AUC of 0.5178 (95% CI, 0.4909-0.5447) compared with the best low-shot method (AUC, 0.5778 [95% CI, 0.5512-0.6044]). Conclusions and Relevance: These findings suggest the potential benefits of using low-shot methods for AI retinal diagnostics when a limited number of annotated training retinal images are available (eg, with rare ophthalmic diseases or when addressing potential AI bias).

Entities:  

Mesh:

Year:  2020        PMID: 32880609      PMCID: PMC7489388          DOI: 10.1001/jamaophthalmol.2020.3269

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  10 in total

1.  Assessment of Deep Generative Models for High-Resolution Synthetic Retinal Image Generation of Age-Related Macular Degeneration.

Authors:  Philippe M Burlina; Neil Joshi; Katia D Pacheco; T Y Alvin Liu; Neil M Bressler
Journal:  JAMA Ophthalmol       Date:  2019-03-01       Impact factor: 7.389

2.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.

Authors:  Varun Gulshan; Lily Peng; Marc Coram; Martin C Stumpe; Derek Wu; Arunachalam Narayanaswamy; Subhashini Venugopalan; Kasumi Widner; Tom Madams; Jorge Cuadros; Ramasamy Kim; Rajiv Raman; Philip C Nelson; Jessica L Mega; Dale R Webster
Journal:  JAMA       Date:  2016-12-13       Impact factor: 56.272

3.  AI for medical imaging goes deep.

Authors:  Daniel S W Ting; Yong Liu; Philippe Burlina; Xinxing Xu; Neil M Bressler; Tien Y Wong
Journal:  Nat Med       Date:  2018-05       Impact factor: 53.440

4.  Addressing Bias in Artificial Intelligence in Health Care.

Authors:  Ravi B Parikh; Stephanie Teeple; Amol S Navathe
Journal:  JAMA       Date:  2019-12-24       Impact factor: 56.272

5.  Dissecting racial bias in an algorithm used to manage the health of populations.

Authors:  Ziad Obermeyer; Brian Powers; Christine Vogeli; Sendhil Mullainathan
Journal:  Science       Date:  2019-10-25       Impact factor: 47.728

6.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

7.  EyePACS: an adaptable telemedicine system for diabetic retinopathy screening.

Authors:  Jorge Cuadros; George Bresnick
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

8.  Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks.

Authors:  Philippe M Burlina; Neil Joshi; Michael Pekala; Katia D Pacheco; David E Freund; Neil M Bressler
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

Review 9.  Introduction to Machine Learning, Neural Networks, and Deep Learning.

Authors:  Rene Y Choi; Aaron S Coyner; Jayashree Kalpathy-Cramer; Michael F Chiang; J Peter Campbell
Journal:  Transl Vis Sci Technol       Date:  2020-02-27       Impact factor: 3.283

10.  A Clinician's Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies.

Authors:  Livia Faes; Xiaoxuan Liu; Siegfried K Wagner; Dun Jack Fu; Konstantinos Balaskas; Dawn A Sim; Lucas M Bachmann; Pearse A Keane; Alastair K Denniston
Journal:  Transl Vis Sci Technol       Date:  2020-02-12       Impact factor: 3.283

  10 in total
  8 in total

1.  Novel Low-Shot Deep Learning Approach for Retinal Image Classification With Few Examples.

Authors:  Matthew S Hunt; Yuka Kihara; Aaron Y Lee
Journal:  JAMA Ophthalmol       Date:  2020-10-01       Impact factor: 7.389

2.  Detecting Anomalies in Retinal Diseases Using Generative, Discriminative, and Self-supervised Deep Learning.

Authors:  Philippe Burlina; William Paul; T Y Alvin Liu; Neil M Bressler
Journal:  JAMA Ophthalmol       Date:  2022-02-01       Impact factor: 7.389

3.  Evaluation of Generative Adversarial Networks for High-Resolution Synthetic Image Generation of Circumpapillary Optical Coherence Tomography Images for Glaucoma.

Authors:  Ashish Jith Sreejith Kumar; Rachel S Chong; Jonathan G Crowston; Jacqueline Chua; Inna Bujor; Rahat Husain; Eranga N Vithana; Michaël J A Girard; Daniel S W Ting; Ching-Yu Cheng; Tin Aung; Alina Popa-Cherecheanu; Leopold Schmetterer; Damon Wong
Journal:  JAMA Ophthalmol       Date:  2022-10-01       Impact factor: 8.253

4.  The Ethical and Societal Considerations for the Rise of Artificial Intelligence and Big Data in Ophthalmology.

Authors:  T Y Alvin Liu; Jo-Hsuan Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-28

5.  Addressing Artificial Intelligence Bias in Retinal Diagnostics.

Authors:  Philippe Burlina; Neil Joshi; William Paul; Katia D Pacheco; Neil M Bressler
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

6.  Feasibility study to improve deep learning in OCT diagnosis of rare retinal diseases with few-shot classification.

Authors:  Tae Keun Yoo; Joon Yul Choi; Hong Kyu Kim
Journal:  Med Biol Eng Comput       Date:  2021-01-25       Impact factor: 3.079

7.  Data Homogeneity Effect in Deep Learning-Based Prediction of Type 1 Diabetic Retinopathy.

Authors:  Jui-En Lo; Eugene Yu-Chuan Kang; Yun-Nung Chen; Yi-Ting Hsieh; Nan-Kai Wang; Ta-Ching Chen; Kuan-Jen Chen; Wei-Chi Wu; Yih-Shiou Hwang; Fu-Sung Lo; Chi-Chun Lai
Journal:  J Diabetes Res       Date:  2021-12-28       Impact factor: 4.011

8.  Artificial Intelligence, Heuristic Biases, and the Optimization of Health Outcomes: Cautionary Optimism.

Authors:  Michael Feehan; Leah A Owen; Ian M McKinnon; Margaret M DeAngelis
Journal:  J Clin Med       Date:  2021-11-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.